Research Site MET097 23-101-001 — Overland Park, Kansas

Research Site MET097 23-101-001 is a clinical research site located in Overland Park, Kansas, United States 66212.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site MET097 23-101-001 has participated in 1 clinical trials.

Therapeutic areas: Obesity and Overweight.

Sponsors: Metsera, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site MET097 23-101-001?

Research Site MET097 23-101-001 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site MET097 23-101-001 conducted?

Research Site MET097 23-101-001 has 1 clinical trials on record. Their work covers Obesity and Overweight.

Is Research Site MET097 23-101-001 accredited by Crixeo Health?

Research Site MET097 23-101-001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site MET097 23-101-001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.